Division of Pediatric Pulmonology, First Department of Pediatrics, National and Kapodistrian University of Athens School of Medicine & Aghia Sophia Children's Hospital, Athens, Greece.
CT, MRI & PET/CT Department, Aghia Sophia Children's Hospital, Athens, Greece.
Clin Imaging. 2021 Jul;75:97-104. doi: 10.1016/j.clinimag.2021.01.011. Epub 2021 Jan 22.
Bronchiolitis obliterans syndrome (BOS) diagnosis in children following allogeneic hematopoietic stem cell transplantation (post-HSCT) is based on detection of airway obstruction on spirometry and air-trapping, small airway thickening or bronchiectasis on chest CT. We assessed the relationship between spirometry indices and low-attenuation lung volume at total lung capacity (TLC) on CT.
Data of children post-HSCT with and without BOS were analyzed. An age-specific, low-attenuation threshold (LAT) was defined as average of (mean-1SD) lung parenchyma attenuation of 5 control subjects without lung disease matched to each age subgroup of post-HSCT patients. % CT lung volume at TLC with attenuation values <LAT was calculated. Association between % lung volume with low attenuation and FEV/FVC was assessed.
Twenty-nine children post-HSCT were referred to exclude BOS and 12 of them had spirometry and an analyzable chest CT. We studied: (i) 6 children post-HSCT/BOS (median age: 8.5 years [IQR 7, 15]; median FEV/FVC z-score: -2.60 [IQR -2.93, -2.14]); (ii) 6 children post-HSCT/no BOS (age: 13.5 years [9.8, 16.3]; FEV/FVC z-score: 0.44 [-0.30, 2.10]); and (iii) 40 controls without lung disease (age:11 years [8.3, 15.8]). Patients post-HSCT/BOS had significantly higher % lung volume with low attenuation than patients post-HSCT/no BOS: median % volume 16.4% (7.1%, 37.2%) vs. 0.61% (0.34%, 2.79%), respectively; P = .004. An exponential model described the association between % CT lung volume below LAT and FEV/FVC z-score (r = 0.76; P < .001).
In children post-HSCT with BOS, low-attenuation lung volume on chest CT is associated with airway obstruction severity as expressed by FEV/FVC z-score.
异基因造血干细胞移植(HSCT)后儿童闭塞性细支气管炎综合征(BOS)的诊断依据是肺量计检测到的气道阻塞和空气潴留、胸部 CT 显示的小气道增厚或支气管扩张。我们评估了肺量计指标与 CT 上总肺活量(TLC)的低衰减肺容积之间的关系。
分析了 HSCT 后存在和不存在 BOS 的儿童数据。根据每个 HSCT 后儿童年龄亚组的 5 名无肺部疾病的对照者的肺实质衰减平均值-1 标准差(mean-1SD),定义了一个年龄特异性的低衰减阈值(LAT)。计算了在 TLC 中衰减值<LAT 的 CT 肺容积百分比。评估了低衰减肺容积百分比与 FEV/FVC 的相关性。
有 29 名 HSCT 后儿童被转诊以排除 BOS,其中 12 名儿童进行了肺量计和可分析的胸部 CT 检查。我们研究了:(i)6 名 HSCT/BOS 后儿童(中位年龄:8.5 岁[IQR 7,15];中位 FEV/FVC z 评分:-2.60[IQR-2.93,-2.14]);(ii)6 名 HSCT/无 BOS 后儿童(年龄:13.5 岁[9.8,16.3];FEV/FVC z 评分:0.44[-0.30,2.10]);和(iii)40 名无肺部疾病的对照者(年龄:11 岁[8.3,15.8])。HSCT/BOS 后患儿的低衰减肺容积百分比明显高于 HSCT/无 BOS 后患儿:中位数分别为 16.4%(7.1%,37.2%)和 0.61%(0.34%,2.79%);P=0.004。一个指数模型描述了 CT 下低于 LAT 的肺容积百分比与 FEV/FVC z 评分之间的关系(r=0.76;P<0.001)。
在 HSCT 后患有 BOS 的儿童中,胸部 CT 上的低衰减肺容积与 FEV/FVC z 评分所表示的气道阻塞严重程度相关。